A61K 38/484
Plasmin
Official title: {Plasmin (3.4.21.7)}
A61K38/484 (Plasmin) appears on 137 US grants and 236 published applications in this corpus.
Search patents in A61K- Granted patents
- 137
- Published applications
- 236
- Assignees
- 101
- Inventors
- 302
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 3 | 7 |
| 2003 | 3 | 15 |
| 2004 | 2 | 6 |
| 2005 | 3 | 11 |
| 2006 | 3 | 11 |
| 2007 | 5 | 10 |
| 2008 | 0 | 11 |
| 2009 | 6 | 11 |
| 2010 | 3 | 7 |
| 2011 | 8 | 11 |
| 2012 | 8 | 9 |
| 2013 | 7 | 13 |
| 2014 | 7 | 7 |
| 2015 | 6 | 5 |
| 2016 | 3 | 5 |
| 2017 | 4 | 6 |
| 2018 | 6 | 8 |
| 2019 | 1 | 25 |
| 2020 | 7 | 8 |
| 2021 | 9 | 9 |
| 2022 | 7 | 6 |
| 2023 | 8 | 18 |
| 2024 | 5 | 8 |
| 2025 | 4 | 4 |
| 2026 | 3 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method and medicine for treating Huntington's disease15 Sep 2026US 12,734,222 B2Talengen International Limited
- Thrombolytic agents for intravascular clots14 Apr 2026US 12,599,653 B2Jinis Co., Ltd.
- Method and drug for treating spinal muscular atrophy17 Mar 2026US 12,576,139 B2Talengen International Limited
- Plasminogen for use in treating and preventing lung dysfunction16 Dec 2025US 12,497,607 B2Previpharma Consulting GmbH
- Magnetic particle control and visualization29 Jul 2025US 12,370,259 B2Pulse Therapeutics, Inc.
- Plasmin-induced internal limiting membrane digestion facilitates donor retinal ganglion cell transplantation8 Oct 2026US 2026/0306549 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Freeze-dried plasma (fdp) for well-balanced coagulation and fibrinolysis, method of preparation and use thereof9 Jul 2026US 2026/0191903 A1Army Medical University, People's Liberation Army, Prc
- Method for promoting pathological tdp-43 protein degradation, and drug18 Jun 2026US 2026/0166131 A1Talengen International Limited
- Method and drug for promoting removal of pathological proteins by ubiquitin proteasome system and autophagy lysosome system18 Jun 2026US 2026/0166132 A1Talengen International Limited
- Thrombolytic agents for intravascular clots4 Jun 2026US 2026/0151464 A1Jinis Co., Ltd.
Most cited
By later US patents
- Therapeutic magnetic control systems and contrast agents95US 10,029,008 B2Pulse Therapeutics, Inc. · 2018
- Pasteurized therapeutically active protein compositions78US 4,440,679 ACutter Laboratories, Inc. · 1984
- Method for regulating size of vascularized normal tissue72US 6,306,819 B1Children's Medical Center Corporation · 2001
- Prevention of posterior capsular opacification57US 6,186,148 B12001
- Modified vaccinia virus strains for use in diagnostic and therapeutic methods40US 8,052,968 B2Genelux Corporation · 2011